Country: Malasía
Tungumál: enska
Heimild: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
MORPHINE SULPHATE
MUNDIPHARMA PHARMACEUTICALS SDN. BHD.
MORPHINE SULPHATE
30 Tablet Tablets; 60 Tablet Tablets; 30Tablet Tablets
BARD PHARM LTD
_MST CONTINUS_ ® TABLETS NAME OF THE MEDICINAL PRODUCT _MST CONTINUS_ ® 10 mg, 30 mg, 60 mg, 100 mg Prolonged Release Tablets QUALITATIVE AND QUANTITATIVE COMPOSITION Tablets containing Morphine Sulfate Ph.Eur, 10 mg, 30 mg, 60 mg, 100 mg. PHARMACEUTICAL FORM Prolonged release, film-coated, biconvex tablets, plain on one side and the strength of the preparation is marked on the other. _MST CONTINUS_ ® tablets 10 mg are golden brown. _MST CONTINUS_ ® tablets 30 mg are purple. _MST CONTINUS_ ® tablets 60 mg are orange. _MST CONTINUS_ ® tablets 100 mg are grey. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS Prolonged relief of severe pain POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: oral _MST CONTINUS_ ® tablets should be swallowed whole and not broken, chewed or crushed. The administration of broken, chewed or crushed tablets may lead to a rapid release and absorption of a potentially fatal dose of morphine (refer to _Overdose)_ . _MST CONTINUS_ ® tablets should be used at 12-hourly intervals. The dosage is dependent upon the severity of the pain, the patient's age and previous history of analgesic requirements. Drug product is not recommended preoperatively or within the first 24 hours postoperatively. Adults: A patient presenting with severe pain, uncontrolled by weaker opioids (e.g. dihydrocodeine) should normally be started on 30 mg 12 hourly. Patients previously on normal release oral morphine should be given the same total daily dose as _MST CONTINUS_ ® tablets but in divided doses at 12-hourly intervals. Increasing severity of pain will require an increased dosage of the tablets. Higher doses should be made, where possible in 30-50% increments as required. The correct dosage for any individual patient is that which is sufficient to control pain with no, or tolerable, side effects for a full 12 hours. It is recommended that the 200 mg strength is reserved for patients who have already been titrated to a stable analgesic dose using lower strengths of morphine or other opioid preparatio Lestu allt skjalið